SPINT2 and non-small cell lung carcinoma: Moreover, we found elevated STYK1 or decreased SPINT2 expression strongly correlated with NSCLC poor prognosis, and downregulation of SPINT2 involved in STYK1-mediated NSCLC progression (Fig. 6h).